636. Myelodysplastic Syndromes: Basic and Translational: Poster III

Impact of different Sf3b1 mutations on hematopoietic function and erythropoiesis

Bone marrow CD57 LGL cells comprised of NK and CD8 T cells drive bone marrow failure in Myelodysplastic Syndromes

SF3B1 mutations K700E K666N and R625H Gene expression and aberrant splicing consequences

Multi‑omics analysis of Del20q reveals PHF20 haploinsufficiency and an HDAC2 centered epigenetic circuit in myeloid neoplasms

Searching for a myelodysplastic syndrome stem cells MDS SCs signature by flow cytometry Toward a new prognostic tool

Germline alterations of hematopoietic growth factor receptors and maladaptive somatic genetic rescue leads to myeloid neoplasia

Predictive biomarkers of luspatercept and erythropoiesis stimulating agent ESA hematological response and overall survival OS in patients with lower risk myelodysplastic syndromes LR MDS in the commands trial

Bone marrow microenvironment overlap between vexas and myelodysplastic syndrome demonstrated by targeted transcriptomic and artificial intelligence

Analysis of CD8 cytotoxic t cells in patients with myelodysplastic syndrome MDS and T cell large granulocyte lymphocytic leukemia T LGLL reveal a distinct phenotype compared to those with t lgll

Investigating suspected germline STAG2 variants in myeloid neoplasms